Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data
Cardiovascular diseases, along with cancer, are the leading causes of death worldwide. Although modern pharmacological treatment of various cardiomyopathies can slow the development of myocardial dysfunction, they have limited effectiveness in patients with end-stage disease. Many researchers believ...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2020-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2733 |
| _version_ | 1797882403690119168 |
|---|---|
| author | L. Yu. Grivtsova O. E. Popovkina N. N. Dukhova O. A. Politiko V. V. Yuzhakov L. A. Lepekhina S. Sh. Kalsina S. A. Ivanov A. D. Kaprin |
| author_facet | L. Yu. Grivtsova O. E. Popovkina N. N. Dukhova O. A. Politiko V. V. Yuzhakov L. A. Lepekhina S. Sh. Kalsina S. A. Ivanov A. D. Kaprin |
| author_sort | L. Yu. Grivtsova |
| collection | DOAJ |
| description | Cardiovascular diseases, along with cancer, are the leading causes of death worldwide. Although modern pharmacological treatment of various cardiomyopathies can slow the development of myocardial dysfunction, they have limited effectiveness in patients with end-stage disease. Many researchers believe that heart transplantation is the only radical treatment in this case. However, the lack of donors and the high operation cost require careful selection of surgical candidates. With the introduction of molecular and cell biology into medical practice, today, stem cell therapy can become an alternative method of nonsurgical restoration of myocardial functions. The most studied and attractive is the use of mesenchymal stem cells (MSCs). MSCs differ from hematopoietic stem cells used as support for hematopoiesis in high-dose chemotherapy by the following features: pronounced trophic effect, immune tolerance, the ability to suppress alloreactivity and autoimmune disorders. An important stage in the implementation of cell therapy is the creation of a cell biobank of MSCs. In A.F.Tsyb Medical Radiological Research Center, this work has been carried out since1984. Asignificant number of experimental studies have been carried out, confirming the possibility of clinical implementation of this approach. A method for obtaining stable cultures of MSCs and cardiomyoblasts from bone marrow cells was developed and approvals were obtained. Experimental studies of cell therapy are also being conducted to overcome anthracycline-induced cardiotoxicity in cancer patients.This article is devoted to practical application of MSC-based therapy, in particular, in cancer patients with cardiotoxicity, as well as to the issues of creating a cell biobank for treatment with MSCs. |
| first_indexed | 2024-04-10T03:34:10Z |
| format | Article |
| id | doaj.art-8da8349dcf30418cbb776a02bb0fd6be |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:34:10Z |
| publishDate | 2020-12-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-8da8349dcf30418cbb776a02bb0fd6be2023-03-13T07:23:30Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252020-12-0119610.15829/1728-8800-2020-27332235Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own dataL. Yu. Grivtsova0O. E. Popovkina1N. N. Dukhova2O. A. Politiko3V. V. Yuzhakov4L. A. Lepekhina5S. Sh. Kalsina6S. A. Ivanov7A. D. Kaprin8Медицинский радиологический научный центр им. А. Ф. Цыба — филиал ФГБУ НМИЦ радиологии Минздрава РоссииМедицинский радиологический научный центр им. А. Ф. Цыба — филиал ФГБУ НМИЦ радиологии Минздрава РоссииМедицинский радиологический научный центр им. А. Ф. Цыба — филиал ФГБУ НМИЦ радиологии Минздрава РоссииМедицинский радиологический научный центр им. А. Ф. Цыба — филиал ФГБУ НМИЦ радиологии Минздрава РоссииМедицинский радиологический научный центр им. А. Ф. Цыба — филиал ФГБУ НМИЦ радиологии Минздрава РоссииМедицинский радиологический научный центр им. А. Ф. Цыба — филиал ФГБУ НМИЦ радиологии Минздрава РоссииМедицинский радиологический научный центр им. А. Ф. Цыба — филиал ФГБУ НМИЦ радиологии Минздрава РоссииМедицинский радиологический научный центр им. А. Ф. Цыба — филиал ФГБУ НМИЦ радиологии Минздрава РоссииМедицинский радиологический научный центр им. А. Ф. Цыба — филиал ФГБУ НМИЦ радиологии Минздрава РоссииCardiovascular diseases, along with cancer, are the leading causes of death worldwide. Although modern pharmacological treatment of various cardiomyopathies can slow the development of myocardial dysfunction, they have limited effectiveness in patients with end-stage disease. Many researchers believe that heart transplantation is the only radical treatment in this case. However, the lack of donors and the high operation cost require careful selection of surgical candidates. With the introduction of molecular and cell biology into medical practice, today, stem cell therapy can become an alternative method of nonsurgical restoration of myocardial functions. The most studied and attractive is the use of mesenchymal stem cells (MSCs). MSCs differ from hematopoietic stem cells used as support for hematopoiesis in high-dose chemotherapy by the following features: pronounced trophic effect, immune tolerance, the ability to suppress alloreactivity and autoimmune disorders. An important stage in the implementation of cell therapy is the creation of a cell biobank of MSCs. In A.F.Tsyb Medical Radiological Research Center, this work has been carried out since1984. Asignificant number of experimental studies have been carried out, confirming the possibility of clinical implementation of this approach. A method for obtaining stable cultures of MSCs and cardiomyoblasts from bone marrow cells was developed and approvals were obtained. Experimental studies of cell therapy are also being conducted to overcome anthracycline-induced cardiotoxicity in cancer patients.This article is devoted to practical application of MSC-based therapy, in particular, in cancer patients with cardiotoxicity, as well as to the issues of creating a cell biobank for treatment with MSCs.https://cardiovascular.elpub.ru/jour/article/view/2733мезенхимальные стволовые клеткикардиомиобластыклеточный биобанкантрациклиныкардиомиоцитыкардиотоксичность |
| spellingShingle | L. Yu. Grivtsova O. E. Popovkina N. N. Dukhova O. A. Politiko V. V. Yuzhakov L. A. Lepekhina S. Sh. Kalsina S. A. Ivanov A. D. Kaprin Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data Кардиоваскулярная терапия и профилактика мезенхимальные стволовые клетки кардиомиобласты клеточный биобанк антрациклины кардиомиоциты кардиотоксичность |
| title | Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data |
| title_full | Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data |
| title_fullStr | Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data |
| title_full_unstemmed | Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data |
| title_short | Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data |
| title_sort | cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell based therapy in the treatment of anthracycline induced cardiotoxicity literature review and own data |
| topic | мезенхимальные стволовые клетки кардиомиобласты клеточный биобанк антрациклины кардиомиоциты кардиотоксичность |
| url | https://cardiovascular.elpub.ru/jour/article/view/2733 |
| work_keys_str_mv | AT lyugrivtsova cellbiobankasanecessaryinfrastructureforthedevelopmentandimplementationofmesenchymalstemcellbasedtherapyinthetreatmentofanthracyclineinducedcardiotoxicityliteraturereviewandowndata AT oepopovkina cellbiobankasanecessaryinfrastructureforthedevelopmentandimplementationofmesenchymalstemcellbasedtherapyinthetreatmentofanthracyclineinducedcardiotoxicityliteraturereviewandowndata AT nndukhova cellbiobankasanecessaryinfrastructureforthedevelopmentandimplementationofmesenchymalstemcellbasedtherapyinthetreatmentofanthracyclineinducedcardiotoxicityliteraturereviewandowndata AT oapolitiko cellbiobankasanecessaryinfrastructureforthedevelopmentandimplementationofmesenchymalstemcellbasedtherapyinthetreatmentofanthracyclineinducedcardiotoxicityliteraturereviewandowndata AT vvyuzhakov cellbiobankasanecessaryinfrastructureforthedevelopmentandimplementationofmesenchymalstemcellbasedtherapyinthetreatmentofanthracyclineinducedcardiotoxicityliteraturereviewandowndata AT lalepekhina cellbiobankasanecessaryinfrastructureforthedevelopmentandimplementationofmesenchymalstemcellbasedtherapyinthetreatmentofanthracyclineinducedcardiotoxicityliteraturereviewandowndata AT sshkalsina cellbiobankasanecessaryinfrastructureforthedevelopmentandimplementationofmesenchymalstemcellbasedtherapyinthetreatmentofanthracyclineinducedcardiotoxicityliteraturereviewandowndata AT saivanov cellbiobankasanecessaryinfrastructureforthedevelopmentandimplementationofmesenchymalstemcellbasedtherapyinthetreatmentofanthracyclineinducedcardiotoxicityliteraturereviewandowndata AT adkaprin cellbiobankasanecessaryinfrastructureforthedevelopmentandimplementationofmesenchymalstemcellbasedtherapyinthetreatmentofanthracyclineinducedcardiotoxicityliteraturereviewandowndata |